AI assistant
Sending…
RAPT Therapeutics, Inc. — Director's Dealing 2021
Aug 9, 2021
32942_dirs_2021-08-09_daeaa6e3-3115-42ac-8564-fc0ab81d0724.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-08-06
Reporting Person: HO WILLIAM (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-06 | Common Stock | M | 3690 | $12 | Acquired | 69106 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-06 | Option (right to buy) | $12 | M | 3690 | Disposed | 2029-10-29 | Common Stock (3690) | Direct |
More from RAPT Therapeutics, Inc.
Regulatory Filings
2026
Mar 18
M&A Activity
2026
Mar 3
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 9
Merger & Acquisition
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2